Patents Examined by Blaine Lankford
  • Patent number: 12043845
    Abstract: The invention provide a method for reducing the amount of acidic species and/or increasing the amount of basic species in a composition comprising a recombinant protein or for increasing the specific production rate of mammalian cells expressing a recombinant protein to simplify subsequent clarification and purification of the recombinant protein, said method comprising culturing mammalian cells expressing said recombinant protein in a cell culture medium comprising citrulline.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: July 23, 2024
    Assignee: Polpharma Biologics S.A.
    Inventors: Louis Boon, Lenneke De Winter, Tomasz Sitar
  • Patent number: 12038429
    Abstract: Devices, systems, and methods for strain-specific identification and assessment of susceptibility of microorganisms based on the response of sensors in a colorimetric sensor array to metabolic products of the microorganism. An exemplary method includes culturing a sample containing microorganisms in a medium and in gaseous communication with a colorimetric sensor array. Sensors in the colorimetric sensor array are exposed to volatile organic compounds produced by the microorganism. The method then includes assessing a resistance of the microorganism to at least one substance. The resistance is assessed based on a response of the sensors in the colorimetric sensor array to the volatile organic compounds produced by the microorganism.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: July 16, 2024
    Assignee: Specific Diagnostics, LLC
    Inventors: Paul A. Rhodes, Soumitesh Chakravorty, Sung Hyun Lim
  • Patent number: 12035709
    Abstract: Embodiments herein relate to systems and methods for thawing cells using magnetic particles, such as Curie-magnetic or NĂ©el-magnetic particles. In an embodiment, a cell storage medium for cryopreservation is included. The cell storage medium can include a cryoprotective agent; and a plurality of particles comprising a magnetic material. In an embodiment, a method for thawing a frozen cell sample is included. The method can include obtaining a frozen cell sample comprising particles, the particles comprising a magnetic material and applying an alternating electromagnetic field to the frozen cell sample to induce heating of the magnetic material. Other embodiments are also included herein.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: July 16, 2024
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Jan Weber, Megan Chrobak, Carolina Villarreal
  • Patent number: 12029764
    Abstract: A method for obtaining epithelial organoids is provided. In one embodiment, the method comprises culturing one or more epithelial ducts, epithelial duct fragments and/or epithelial stem cells isolated therefrom in contact with an extracellular matrix in the presence of a basal medium, wherein the medium is free of FGF and/or nicotinamide. Organoids obtained by the methods described herein, and uses thereof, are also provided.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: July 9, 2024
    Assignee: STEMCELL TECHNOLOGIES CANADA INC.
    Inventors: Charis-Patricia Segeritz, Ryan Conder, Michael Riedel
  • Patent number: 12023380
    Abstract: Combined therapy of cancer using an immune check point modulators (e.g., an immune checkpoint inhibitor) and a fermented product, which may be prepared using symbiotic microbiota.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: July 2, 2024
    Assignee: MICROBIO CO. LTD.
    Inventor: Kung-Ming Lu
  • Patent number: 12006510
    Abstract: Provided herein are methods of culturing a mammalian cell and various methods that utilize these culturing methods. Also provided are multi-well cell culture plates, e.g., for use in perfusion culturing methods.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: June 11, 2024
    Assignee: Genzyme Corporation
    Inventors: Agata Villiger-Oberbek, Jianguo Yang, Yang Yang, Gabrielle Lorenzo
  • Patent number: 11985968
    Abstract: Compositions for maintaining cellular integrity especially in cases of cryopreservation and multiple freeze/thawing cycles are provided. In addition, the compositions can be used in various media for a variety of applications.
    Type: Grant
    Filed: August 6, 2020
    Date of Patent: May 21, 2024
    Assignee: Akron Biotechnology, LLC
    Inventor: Claudia Zylberberg
  • Patent number: 11986498
    Abstract: This invention provides a fluid therapeutic placental product comprising placental cells and a placental dispersion comprising placental factors. The placental cells and the placental dispersion are derived from placental tissue. A placental tissue can optionally be an amnion, chorion, or a trophoblast-depleted chorion. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: May 21, 2024
    Assignee: OSIRIS THERAPEUTICS, INC.
    Inventors: Timothy Jansen, Samson Tom, Alla Danilkovitch, Dana Yoo, Jaime Zerhusen
  • Patent number: 11986288
    Abstract: Described here are patches and methods for measuring glucose in sweat (and tears and the like). In general, the patches comprise an adhesive layer adapted to bond to skin of an individual, a substrate layer disposed over the adhesive layer and comprising a glucose sensing complex including a chromogen that changes color in the presence of certain concentrations of glucose, and a cover. In typical embodiments, the substrate layer has elements formed to direct and accumulate sweat that migrates from the skin of the individual to the glucose sensing complex. Methods of using the invention can comprise cleaning the skin surface, collecting sweat in a patch comprising this microfluidic constellation of elements, and observing concentrations of glucose collected in the sweat, for example either visually, or by using a smartphone or other computer processing device.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: May 21, 2024
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Ashwin K. Rao, Rebecca K. Gottlieb, Quyen Ong
  • Patent number: 11959840
    Abstract: A tissue sample that has been removed from a subject can be evaluated. A change in speed of the energy traveling through the sample is evaluated to monitor changes in the biological sample during processing. The monitoring can detect movement of fluid with the sample and cross-linking. A system for performing the method can include a transmitter that outputs the energy and a receiver configured to detect the transmitted energy.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: April 16, 2024
    Assignee: Ventana Medical System, Inc.
    Inventors: Jefferson Curtis Taft, David Chafin, Michael Otter, Benjamin Stevens
  • Patent number: 11959903
    Abstract: Techniques and systems are disclosed for a bioassay that is an in vitro mimic of peripheral nerve generation using the sensory neurons that innervate the peripheral nervous system. In some embodiments, the techniques may assist in detecting the bioactivity or potency of nerve grafts (e.g., processed, acellular human allografts) for fostering or supporting peripheral nerve regeneration. In various embodiments, techniques comprise affixing a harvested sensory neuron (e.g., a DRG) to a nerve graft segment to form a test construct; culturing the test construct in a medium; analyzing the test construct to indicate the amount of outgrowing peripheral nerve structure; and determining the potency of the nerve graft from a metric derived from the analysis. In some embodiments, techniques and materials may be used to test the effect of a varied test condition on peripheral nerve growth.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: April 16, 2024
    Assignee: Axogen Corporation
    Inventor: Curt Deister
  • Patent number: 11950590
    Abstract: The present disclosure provides methods to improve the viability of an organ, or organs, by continuously administering a composition comprising NOx gas directly to the organ(s).
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: April 9, 2024
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventor: Jim Potenziano
  • Patent number: 11938173
    Abstract: Provided are methods for repairing a wound or inducing the proliferative phase of a wound comprising administering a composition comprising a protease mixture comprising collagenases and a neutral protease to the wound in an amount effective for repair of wound tissue or for inducing the proliferative phase in the wound.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: March 26, 2024
    Assignee: SMITH & NEPHEW, INC.
    Inventors: Ira Herman, Vincent Ronfard, Lei Shi
  • Patent number: 11940441
    Abstract: Provided herein relates to systems and methods for producing and using a body having a central channel separated by one or more membranes. The membrane(s) are configured to divide the central channel into at least one mesochannel and at least one microchannel. The height of the mesochannel is substantially greater than the height of the microchannel. A gaseous fluid can be applied through the mesochannel while a liquid fluid flowing through the microchannel. The systems and methods described herein can be used for various applications, including, e.g., growth and differentiation of primary cells such as human lung cells, as well as any other cells requiring low shear and/also stratified structures, or simulation of a microenvironment in living tissues and/or organs (to model physiology or disease states, and/or to identify therapeutic agents and/or vaccines). The systems and methods can also permit co-culture with one or more different cell types.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: March 26, 2024
    Assignee: President and Fellows of Harvard College
    Inventors: Donald E. Ingber, Kambez Hajipouran Benam, Remi Villenave, Geraldine A. Hamilton, Bryan Hassell, Christopher D. Hinojosa, Carolina Lucchesi
  • Patent number: 11932843
    Abstract: A device for aseptically obtaining a physical sample of an adherent cell culture substrate from an adherent cell culture bioreactor. This enables the operator to directly evaluate e.g., cell density/confluence on the substrate without contaminating the cell culture.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: March 19, 2024
    Assignee: TRIZELL LTD.
    Inventors: Vesa Turkki, Nigel Parker
  • Patent number: 11932584
    Abstract: The method grows a mycelial mass over a three-dimensional lattice such that a dense network of oriented hyphae is formed on the lattice. Growth along the lattice results in mycelium composite with highly organized hyphae strands and allows the design and production of composites with greater strength in chosen directions due to the organized nature of the supporting mycelia structure.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: March 19, 2024
    Assignee: ECOVATIVE DESIGN LLC
    Inventors: Eben Bayer, Gavin McIntyre
  • Patent number: 11918609
    Abstract: The present invention provides a method for treating wounds by applying cells as described in this application. In one aspect the method provides treatment for cutaneous wounds. In general embodiments the cells are delivered to the wound without being attached to a functionalized substrate in the delivery vehicle.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: March 5, 2024
    Assignees: ABT HOLDING COMPANY, KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Aernout Luttun, Robert J. Deans
  • Patent number: 11918674
    Abstract: The present invention relates to the novel trypsin ZT isoforms. In particular, the invention relates to the use of trypsin ZT isoforms in medical devices, pharmaceuticals and cosmetics.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: March 5, 2024
    Assignee: ENZYMATICA AB
    Inventors: Agusta Gudmundsdottir, Asgeir Asgeirsson, Bjarki Stefansson
  • Patent number: 11903397
    Abstract: There is provided a method of treating hay for preventing and/or reducing heat damage in high moisture hay and as well to preserve the same, the method including adding to hay a hay preservative including a hay preserving and heat reducing effective amount of at least one enzyme having a chitinase activity, either alone or in combination with a hay preserving and heat reducing effective amount of a yeast of the genus Pichia or a bacteria of the genus Pediococcus. There is also provided a method of treating hay for preventing and/or reducing heat damage in high moisture hay and as well to preserve the same, the method including adding to hay a hay preservative including a hay preserving and heat reducing effective amount of yeast of the genus Pichia.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: February 20, 2024
    Assignee: DANSTAR FERMENT AG
    Inventors: Julien Sindou, Henri Durand
  • Patent number: 11896626
    Abstract: Provided herein are multi-strain population control systems, methods, kits, and compositions. Also provided are methods, systems, kits, and compositions for culturing bacterial cells in multi-strain ecosystems, and temporally arranged multi-strain ecosystems or cultures using a synchronized lysis circuit in combination with multiple toxin/antitoxin systems to cycle continuously over a long period of time.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: February 13, 2024
    Assignee: The Regents of the University of California
    Inventors: Jeff Hasty, Michael Julius Liao, Muhammad Omar Din